The Dna Damage Checkpoint Protein Atm Promotes Hepatocellular Apoptosis And Fibrosis In A Mouse Model Of Non-Alcoholic Fatty Liver Disease by Daugherity, Erin
   The DNA Damage Checkpoint Protein ATM 
Promotes Hepatocellular Apoptosis and Fibrosis in a 
Mouse Model of Non-Alcoholic Fatty Liver Disease 
 
 
 
A Thesis 
Presented to the Faculty of the Graduate School 
of Cornell University 
in Partial Fulfillment of the Requirements for the Degree of  
Master of Science 
 
 
 
by 
Erin Daugherity, D.V.M. 
January, 2013 
  
 
 
 
 
 
 
 
 
 
© 2013 Erin Daugherity 
 ABSTRACT 
Steatoapoptosis is a hallmark of non-alcoholic fatty liver disease (NAFLD) and is an important 
factor in liver disease progression. We hypothesized that increased reactive oxygen species 
resulting from excess dietary fat contribute to liver disease by causing DNA damage and 
apoptotic cell death, and tested this by investigating the effects of feeding mice a high fat or 
standard diets for 8 weeks. High fat diet feeding resulted in increased hepatic H2O2, superoxide 
production, and expression of oxidative stress response genes, confirming that the high fat diet 
induced hepatic oxidative stress. High fat diet feeding also increased hepatic steatosis, hepatitis, 
and DNA damage as exemplified by an increase in the percentage of 8-hydroxyguanosine (8-
OHG) positive hepatocytes in high fat diet fed mice. Consistent with reports that the DNA 
damage checkpoint kinase Ataxia Telangiectasia Mutated (ATM) is activated by oxidative stress, 
ATM phosphorylation was induced in the livers of wild-type mice following high fat diet 
feeding. We therefore examined the effects of high fat diet feeding in Atm-deficient mice.  The 
prevalence of apoptosis and expression of the pro-apoptotic factor Puma were significantly 
reduced in Atm-deficient mice fed the high fat diet when compared to wild-type controls.  
Furthermore, high fat diet fed Atm-/- mice had significantly less hepatic fibrosis than Atm+/+ or 
Atm
+/-
 mice fed the same diet. Together, these data demonstrate a prominent role for the ATM 
pathway in the response to hepatic fat accumulation and link ATM activation to fatty liver-
induced steatoapoptosis and fibrosis, key features of NAFLD progression. 
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CHAPTER ONE: 
INTRODUCTION 
The spectrum of Non-Alcoholic Fatty Liver Disease 
Nonalcoholic fatty liver disease (NAFLD) is an emerging health epidemic with a poorly 
understood pathogenesis and limited therapeutic options [1]. Based on epidemiological, clinical 
and biochemical data, NAFLD is the hepatic manifestation of metabolic syndrome, which 
includes obesity, dyslipidemia, and insulin resistance [2].  NAFLD comprises a spectrum of 
hepatic lesions ranging from steatosis with deposition of triglycerides within hepatocytes to the 
more aggressive nonalcoholic steatohepatitis (NASH) which includes hepatitis and fibrosis [1,3]. 
Fatty liver disease is currently the most common chronic liver condition in Western countries 
and is highly prevalent in the U.S. with an estimated 30% of the population possessing NAFLD 
and 6% suffering from NASH (Figure 1). These numbers rise to 90% and 30% respectively when 
obese populations are examined [4]. Simple steatosis is generally considered to be benign, but  
 
 
 
 
 
Figure 1: Prevalence of Non-alcoholic fatty liver disease. NAFLD describes a wide spectrum 
of liver disease, including hepatic cirrhosis and associated complications.  
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the accumulation of hepatic inflammatory infiltrates during NASH is considered to be the 
precursor to more aggressive liver disease. NASH-induced complications are severe and 
approximately one-third of NASH patients develop cryptogenic or idiopathic cirrhosis and may 
progress to hepatocellular carcinoma (HCC) [1,3,5].  
 
Hepatocellular carcinoma (HCC) 
Hepatocellular carcinoma is the most common primary cancer of the liver. It is currently 
the fifth most common cause of cancer worldwide, is the third leading cause of cancer death 
behind cancers of the lung and stomach and is increasing in incidence, particularly in 
industrialized countries [3,6]. Over the past 20 years in the United States, there has been an 80% 
increase in the yearly incidence of HCC despite a decrease in historical risk factors, which 
include chronic hepatitis B and C infection, alcohol consumption, aflatoxin exposure, and 
autoimmune hepatitis [3,6] . The major risk factor for the development of HCC is hepatic 
cirrhosis with cirrhosis being present in approximately 80%-90% of HCC patients, but 
approximately one fourth of HCC cases diagnosed in the United States do not possess known 
predisposing risk factors for cirrhosis [6,7].  Moreover, the increase in incidence of HCC over 
the past 20 years is thought to be due, in part, to the emergence of the spectrum of non-alcoholic 
fatty liver diseases, including cirrhosis formation in the liver. There is a clear link between 
dietary fat consumption, fatty liver disease, and hepatocellular carcinoma formation; however, 
the factors that promote the progression of NAFLD to NASH and its associated complications 
currently are not well understood [3,6,8,9].  
 
3 
Fatty liver disease and oxidative stress 
The initial accumulation of lipids in the liver is considered the “first hit” during NAFLD 
pathogenesis and renders hepatocytes more susceptible to oxidative stress. Reactive oxygen 
species (ROS), including superoxide anion and hydrogen peroxide, are by-products of normal 
cellular metabolism.  However, when excess amounts of substrate, such free fatty acids, are 
metabolized, harmful ROS accumulate within the cellular compartment [10]. Increase ROS 
production due to excess FFA has been demonstrated by numerous models of fatty liver disease 
[11,12]. Oxidative stress is a state where the generation of ROS exceeds the removal or redox of 
these products from the cell [10,13]. The presence of hepatic oxidative stress is regarded as the 
“second hit” of NAFLD pathogenesis. After inflammation accompanies the steatosis and the 
condition is considered NASH, there is an increase in oxidative stress, as well as the 
accumulation of fibrosis, more extensive liver damage, and in some cases, there is development 
of HCC [10,13,14,15].  Xu et al [16] revealed that hepatocytes deficient in nuclear respiratory 
factor 1 (Nrf1), a transcription factor which upregulates key antioxidant genes essential during 
oxidative stress, had increased susceptibility to oxidative stress which resulted in hepatic 
apoptosis, inflammation and fibrosis, and ultimately led to HCC development. Additionally, 
activation of inflammatory cell infiltrates contributes to reactive oxygen species (ROS) 
production and to the progression of NAFLD to NASH [17]. Overall, the occurrence of oxidative 
stress is a hallmark of fatty liver disease progression. In fact, it has been documented that higher 
levels of oxidative stress correlates with increasing disease severity. 
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Fatty liver disease, steatoapoptosis and carcinogenesis 
During NAFLD/NASH, an excessive amount of nonesterified free fatty acids (FFAs) 
overwhelm the ability of the liver to convert FFAs to triglycerides, resulting in apoptotic cell 
death, a process known as steato- or lipo-apoptosis [18,19]. In both humans and animal models, 
hepatocyte apoptosis correlates with NASH severity and fibrosis stage, suggesting 
steatoapoptosis plays a causative role in disease progression[12,19,20,21,22]. However, the exact 
mechanisms and cellular pathways linking hepatic lipid accumulation to steatoapoptosis and the 
progression of NAFLD/NASH remain largely unknown. Oxidative stress may have a central 
role, as oxidative metabolism is increased in NAFLD patients [23] and recent studies indicate 
that saturated FFAs induce apoptosis through the generation of reactive oxygen species [22]. 
Excessive ROS production induces apoptosis via various pathways, including the extrinsic 
pathway of apoptosis which utilizes death receptor signaling, and the intrinsic pathway of 
apoptosis which involves mitochondrial and endoplasmic reticulum stress and p53 upregulated 
modulator of apoptosis (PUMA) signaling [20,24]. PUMA is a pro-apoptotic BH3-only protein 
that both directly and indirectly activates other members of the Bcl-2 protein family, such as Bax 
and Bak, ultimately leading to mitochondrial dysfunction and apoptosis [24,25].  
In addition to the hypothesis that apoptosis provides a protective function against 
tumorigenesis, it has been hypothesized that apoptosis evasion contributes to early tumorigenesis 
in general, as well as resistance to chemotherapy [24]. Several recent studies utilizing PUMA-
deficient mice revealed that loss of PUMA prevented γ-irradiation induced apoptosis, 
compensatory hematopoietic stem cell proliferation, and lymphomagenesis, suggesting that cell 
death as well as progenitor cell expansion are needed for DNA damage induced tumor formation 
and that following apoptosis the repopulation with hepatic progenitor cells carrying mutations 
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can drive tumorigenesis [24,26,27].  Moreover, Luedde et al [28] revealed that inhibiting hepatic 
NF-ĸB, an anti-apoptotic inflammatory cytokine that is activated in many tumor types, resulted 
in steatohepatitis, increased apoptosis, and HCC development, most likely through compensatory 
hepatic proliferation. Interestingly, this phenomenon is also seen in patients with viral or alcohol 
induced HCC where hepatocytes and bi-potential oval cells serving as functional stem cells of 
the liver repeatedly proliferate through cycles of hepatocyte death and regeneration [29,30].  
Additionally, chemotherapy failure can be caused by re-population with drug resistant stem cells 
[30,31]. Conversely, mouse models indicate that PUMA deficiency accelerates c-Myc induced 
lymphomagenesis and chemical induced intestinal tumorigenesis [24,32,33]. In addition, 
Nakanishi et al [34] established that runt-related transcription factor 3 (RUNX3), a pro-apoptotic 
factor and gastric cancer tumor suppressor that is downregulated in 30-80% of HCCs, increases 
starvation-induced apoptosis in HCC cell lines and that deleting RUNX3 leads to tumorigenesis 
by escaping apoptosis. Collectively, these studies suggest that either an increase or decrease in 
apoptosis can have both a causal and a protective effect on hepatic carcinogenesis.   
 
Fatty liver disease, hepatic fibrosis and carcinogenesis:   
It is well established that chronic liver injury, as seen during fatty liver disease 
progression, results in progressive fibrinogenesis caused predominantly by the activation of 
hepatic stellate cells to a myofibroblast phenotype thereby producing excess extracellular matrix. 
Importantly, advanced fibrosis is the largest single risk factor for HCC development 
[6,35,36,37]. This risk is emphasized in a current case study from Japan of patients with 
6 
diagnosed NASH that progressed to HCC where cirrhosis was present in 51% of the cases and 
advanced stages of fibrosis were present in 72% of the cases [37]. 
Significant pro-fibrinogenic mechanisms include oxidative stress and chronic 
inflammation. A recent model proposed by Matsuzaki identifies chronic inflammation as a 
predominant fibro-carcinogenesis driver via Smad protein signaling, which conveys signals from 
TGF-β receptors to the nucleus, including a shift from the pSmad3C to the pSmad3L pathway 
thus accelerating liver fibrosis and increasing the risk of HCC[35]. Therefore, hepatic fibrotic 
and inflammatory responses provide a link between fatty liver disease hepatocarcinogenesis.  
 
Fatty liver disease, DNA damage and HCC formation: 
The exact mechanism of carcinogenesis during NAFLD/NASH remains unknown, but 
three essential components of carcinogenesis are thought to be involved, including 
carcinogenesis initiation due to oxidative stress and lipid peroxidation; carcinogenesis promotion 
due to hepatocellular apoptosis and proliferation; and neoplastic progression due to oxidation-
induced mutations [3,6]. ROS can induce DNA damage and is one of the most common causes 
of hepatic genomic instability [38]. Oxidized bases are repaired primarily by the DNA base 
excision repair (BER) pathway.  8-Hydroxyguanosine (8-OHG), an oxidized form of the 
nucleotide guanine, is the major product produced when DNA is oxidatively attacked. If left un-
repaired, 8-OHG results in A:T to C:G or G:C to T:A transversion mutations in both 
mitochondrial and nuclear nucleic acids and causes genomic instability [10,13]. It is clear that 
oxidative stress and DNA damage play a role during the progression of fatty liver disease to 
hepatic carcinogenesis; thus, utilizing a model that is involved in both DNA damage and repair 
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and the cellular response to ROS accumulation is essential to determining the exact links 
between hepatic fat accumulation and hepatocellular carcinoma formation. 
 
Ataxia Telangiectasia and the Ataxia Telangiecatsia Mutated (ATM) protein kinase 
Ataxia-Telangiectasia (A-T) is a rare autosomal recessive disorder in humans caused by 
the deficiency of the protein kinase ataxia telangiectasia mutated (ATM). Worldwide, there is one 
case of A-T in every 40,000 to 100,000 live births [39]. The majority of A-T patients generate 
non-functional, unstable, truncated ATM protein due to missense or nonsense mutations in the 
ATM gene [40]. ATM is a member of the phosphoinositide 3-kinase-related protein kinase 
(PIKK) family of Ser/Thr-protein kinases, which also includes ataxia-telangiectasia and RAD-
3related (ATR), DNA-dependent protein kinase catalytic subunit (DNA-PKcs) and mammalian 
target of rapamycin (mTOR) [41,42]. ATM is a major cellular regulator of the response to double 
strand DNA breaks (DSB), and consequently, A-T patients cannot respond to DSB properly, 
resulting in a variety of deleterious phenotypes including progressive cerebellar ataxia, 
oculocutaneous telangiectasia, immunodeficiency, premature aging, sterility, chromosomal 
instability, shortened lifespan, sensitivity to ionizing radiation and cancer predisposition, 
particularly lymphoid tumorigenesis [41,43]. Moreover, polymorphisms and mutations in the 
Atm gene are linked to an elevated cancer risk, including lung and breast cancer, glioma, and 
hereditary pancreatic ductal adenocarcinoma [44,45,46].  Further, immune system phenotypes 
are most likely due to the inability to process and repair DNA strand breaks that naturally occur 
during V(D)J and class switch recombination [47,48]. 
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ATM and the DNA damage response 
Members of the PIKK family protect the genomic integrity of eukaryotic cells through 
the activation of cell cycle checkpoints and by activating DNA repair. While ATR is activated by 
single stranded DNA, both ATM and DNA-PKcs are activated by DNA DSBs but initiate 
different DNA repair pathways. DNA-PKcs is recruited and activated by the interaction with Ku 
heterodimer and promotes the non-homologous enjoining DNA repair pathway. Conversely, 
ATM is activated by DNA damage through interactions with the MRE-11-RAD50-NBS1 (MRN) 
complex and promotes DNA repair through the homologous recombination pathway following 
DNA end-processing [41]. Failure to activate ATM after DNA damage leads to defective cell 
cycle control and impaired DNA repair. 
ATM exists as an inactive dimer that undergoes autophosphorylation at Ser1981and 
subsequent monomerization during activation due to DNA damage [49]. Autophosphorylation of 
ATM at Ser1981 is required for the retention of ATM at the site of the DSB, but is not required 
for the recruitment of ATM to the site of damage [50].  Once activated, ATM regulates the G1-S 
cell cycle checkpoint through phosphorylation of p53 at Ser15 and checkpoint kinase 2 (CHK2) 
at Thr68 [51,52], which then phosphorylates intermediary protein substrates including BRCA1, 
CDC25A , and CDC25 [41]. Additionally, phosphorylation of the histone H2AX, a marker of 
DNA double stranded breaks, occurs concurrently with ATM activation due to DNA damage 
[42].  ATM also regulates the intra-S checkpoint through the phosphorylation of SMC1 [42]. 
Furthermore, ATM-induced p53 phosphorylation leads apoptosis and senescence if the DNA 
damage cannot be properly repaired (Figure 2) [51,53].  Finally,  several hundred ATM substrates 
have been identified following ionizing radiation, which induces DNADSBs, many of which 
have roles in the DNA damage response or  function during cell cycle checkpoint arrest, but also 
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include targets that dot not play a role in these pathways [54]. Additionally, there are numerous 
phosphorylation events that occur as a result of DNA damage that are ATM-dependent but are 
not directly catalyzed by ATM, further highlighting the central role ATM plays in the cellular 
response to DNA damage. 
 
 
 
 
 
 
 
 
Figure 2: The ATM pathway is activated due to DNA double stranded breaks and directly 
by ROS. ATM activation either by double strand breaks or by ROS results in the activation of 
many downstream, substrates, including CHK2 and p53, which then activates pro-apoptotic 
PUMA, leading to cell cycle checkpoint arrest and DNA repair, or to apoptosis. When activated 
by double strand breaks, there is concurrently phosphorylation of H2AX, which is not seen when 
ATM is directly activated by ROS. 
 
ATM and the cellular response to oxidative stress 
Various studies suggest that the neurodegenerative phenotypes observed in A-T patients 
are not related to genomic instability caused by deficiency of ATM, but are the result of loss of 
ATM function independent of DNA damage, partly due to the fact that post-mitotic cerebellar 
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neurons do not completely rely on ATM-mediated cell cycle regulation [41]. Further, ATM is 
implicated in metabolic disease characterized by a variety of conditions including insulin 
resistance, glucose intolerance, elevated serum cholesterol and lipid levels, and atherosclerosis 
[41,55]. Evidence now links ATM deficiency with elevated oxidative stress and deregulation of 
cellular metabolic functions. For instance, ATM deficient cells have reduced levels of antioxidant 
compounds and are hypersensitive to treatment with oxidizing agents, and this oxidative stress 
can be alleviated with the administration of antioxidant compounds [41,42]. Cultured Atm-
deficient cells are more sensitive to oxidative stress [13] and hepatocytes with excess fat are 
exceptionally vulnerable to oxidative stress and DNA damage [5,10,23]. Moreover, a fraction of 
the ATM protein has been shown to be present in the cytoplasm of various cell types, notably in 
cerebellar neurons, despite the fact that it is considered to be generally localized to the nucleus 
[41]. These facts provide evidence for the role of ATM in cellular response to oxidative stress. 
It is now known that ATM can be directly activated by ROS (Figure 2). When activated 
by ROS, ATM exists as an active dimer with two monomers covalently linked by disulfide bonds 
[41]. Guo et al [42] treated primary human fibroblasts with the oxidizing agent hydrogen 
peroxide (H2O2), or with bleomycin, which induces DNA DSBs. ATM autophosphorylation  
occurred in response to both treatments, and activation of ATM by H2O2 occurred independently 
of free DNA ends and the MRN complex. However, when the group mutated Serine 1981 to 
alanine in order to prevent ATM autophosphorylation, oxidized ATM retained the ability to 
phosphorylate downstream p53, demonstrating that autophosphorylation is not required for ATM 
activation by ROS [42]. Additional evidence supporting the hypothesis that ATM activation by 
ROS is a distinct mechanism from that during ATM activation by DNA damage, treatment of 
human fibroblasts with H2O2 resulted in subsequent phosphorylation of p53 and CHK2, but not 
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in phosphorylation of histone H2AX or the heterochromatin protein KAP1, both of which 
accompany DSB formation. This study also demonstrated that substrate specificity during ATM 
activation by ROS is not the same as the specificity during activation by DNA damage. Further, 
chromosomal abnormalities and oxidative DNA lesions in ATM null embryonic stem cells were 
also prevented with antioxidant treatment [56].  Li et al [57] demonstrated that aneuploidy 
increased ROS levels and oxidative DNA damage which induced ATM-dependent p53 activation. 
This response was abrogated with antioxidant treatment providing evidence that ATM responds 
to oxidative stress in vivo. Loss of ATM in these mice accelerated the onset of tumor 
development. These studies emphasize that ATM’s dual roles in both the DNA damage response 
and the cellular response to oxidative stress play a part in tumor suppression. 
 
Currently, the factors that promote the progression of NAFLD to NASH and its 
associated complications including hepatic cirrhosis and hepatocellular are not well understood. 
Due to the increasing prevalence of NAFLD/NASH and the clear connection to complications 
including HCC, the overall objective of this study was to establish and characterize an inducible 
animal model capable of mechanistically evaluating the interaction between hepatic fat 
accumulation, DNA damage, oxidative stress and NAFLD/NASH disease progression. We 
hypothesize that increased reactive oxygen species resulting from excess dietary fat contribute to 
liver disease progression by causing hepatic oxidative stress and DNA damage, resulting in 
apoptotic cell death and a compensatory hepatic fibrotic response (Figure 3). We tested this by 
investigating the effects of feeding mice high fat or standard diets for 8 weeks. 
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Figure 3: High fat diet feeding leads to hepatic oxidative stress and DNA damage, 
contributing to fatty liver disease progression. Excess free fatty acids from feeding a high fat 
diet are metabolized, leading to excess ROS release, which damages hepatocytes, and react with 
lipid to form highly toxic peroxylipids. This combination leads to hepatic oxidative stress and 
DNA damage. Inflammation accompanying the lipid accumulation also contributes to the 
oxidative DNA damage. When DNA damage response pathways and the cellular responses to 
ROS are intact, this DNA damage is repaired and the oxidative stress on the cell is reduced.  
However, when these pathways are not intact, this damage and stress may not be processed 
properly, which could lead to changes in apoptosis, fibrosis, and carcinogenesis. 
 
Our results demonstrate that lipid-laden hepatocytes experience increased oxidative stress 
and undergo ATM–dependent steatoapoptosis, which occurs independently of detectable H2AX 
phosphorylation. These findings provide strong evidence that an ATM-mediated DNA damage 
response contributes to NAFLD progression by promoting apoptosis and fibrosis in the liver.  
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CHAPTER TWO: 
MATERIALS AND METHODS 
 
Animal Husbandry 
Atm null mice were used on a FVB/N strain background [58]. Atm
+/-
 mice were 
intercrossed and progeny were divided into four study groups. In the first and second group, 
Atm
+
 (Atm
+/+
 and Atm
+/-
) and Atm
-/-
 mice were fed a standard diet (SD) (<0.05% cholesterol, 0% 
cholic acid, 5% triglyceride; 7012 Harlan Teklad LM-485 Mouse/Rat Sterilizable Diet) and in 
the third and fourth groups, Atm
+
 and Atm
-/-
 mice were fed a high fat diet (HFD) (1.25% 
cholesterol, 0.5% cholic acid, 15.5%  triglyceride; TD.880511, Harlan, Teklad Lab Animal 
Diets; “Paigen diet”) (Table 1) for eight weeks.  
 
Table 1: Selected nutrient information of the high fat diet.  
 % by weight % kcal 
Protein 19.7 20.5 
Carbohydrate 40.7 42.4 
Fat (half from cocoa butter) 15.8 37.1 
 
 
Initially, both sexes were assessed separately; however, no differences were seen between the 
sexes and male and female data were combined (data not shown). Likewise, data from Atm
+/-
 and 
Atm
+/+
 mice were initially evaluated independently and combined when data indicated there 
were no differences between these groups. A subset of mice was whole body irradiated with 10 
Gy irradiation 8 hours prior to tissue collection. Mice were housed under specific pathogen-free 
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conditions in an Association for the Assessment and Accreditation of Laboratory Animal Care 
International accredited facility. Mice received food and water ad libitum. All protocols were 
approved by the Cornell University Institutional Animal Care and Use Committee.  
 
Tissue Harvest and Histopathology 
After eight weeks of HFD or SD feeding, mice were euthanized with CO2. The liver was 
removed aseptically and weighed. Approximately 30mg of liver was flash frozen in both liquid 
N2 and in Tissue-Tek O.C.T. (Sakura Finetek USA) and stored at -80
o
C. The remainder of the 
liver was fixed in 10% neutral buffered formalin. Tissues were processed, paraffin embedded, 
cut into 4-5μ sections, and stained with hematoxylin and eosin. Additional liver sections were 
stained with Oil Red-O or pico- Sirius Red. Tissues were evaluated by a pathologist blinded to 
sample identity and study design. Hepatic fat accumulation, inflammation and fibrosis were 
scored on an ascending 0-4 scale [59].  
 
Quantitative PCR  
RNA was extracted from liver samples using the E.Z.N.A Total RNA Kit (Omega) and 
residual genomic DNA was removed with DNase treatment (Omega), using the manufacturer’s 
recommendations. Total RNA (1-2μg) was used for synthesis of complimentary DNA (qScript 
cDNA Synthesis Kit; Quanta Biosciences). PerfeCTa SYBR Green FastMix, Low ROX 
quantitative polymerase chain reaction (PCR) Master Mix (Quanta Biosciences) was used for the 
quantitative PCR reaction utilizing Applied Biosystems 7500. Gene expression levels were 
normalized to Gapdh expression and quantification was determined via the ΔΔCT method using 
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the Atm
+
 SD group as the comparative delta value (expression of 1). Error bars represent relative 
log conversion of standard error as described previously [60].  Primer sets were acquired 
(Integrated DNA Technologies) as follows: glyceraldehyde-3-phosphate dehydrogenase 
(Gapdh), p22phox, Puma, Fas, and Fas Receptor. 
 
Immunohistochemistry 
Hepatocyte apoptosis was quantified by terminal deoxynucleotidyl transferase-mediated 
deoxyuridine triphosphate nick-end labeling per manufacturers recommendation (TUNEL; 
ApopTag Peroxidase In Situ Apoptosis Detection Kit; Millipore).  Positive staining was detected 
with 3,3'-diaminobenzidine tetrahydrochloride (DAB) (Invitrogen) and sections were 
counterstained with hematoxylin.   Liver sections from 5 animals per group were TUNEL 
stained. For each section, four 20X fields were chosen randomly and the number of TUNEL-
positive and TUNEL-negative hepatocytes were quantified.  
 
Immunohistologic detection of phosphorylated H2AX was determined on formalin-fixed, 
paraffin embedded liver sections. Briefly, sections were deparaffinized and rehydrated. Antigen 
retrieval was performed by heating the samples to 95
o
C in 0.25 mM EDTA, pH 8, over 50 
minutes. Sections were treated with 3% H2O2 for 10 minutes and blocked with 4% bovine serum 
albumin and 20% Tween in 1XTBS at room temperature and then incubated overnight with 
primary antibody (1:200 dilution; mouse monoclonal anti-γH2AX antibody; Millipore) at 4oC. 
Slides were treated with biotinylated secondary antibody for 20 minutes and detected with 
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Histostain Kit (Invitrogen). Quantification of positive γH2AX hepatocytes was performed in the 
same manner described for TUNEL staining. 
 
Hydrogen Peroxide, 8-hydroxyguanosine, phospho-ATM and Dihydrorhodamine Imaging 
and Quantification  
Hepatic H2O2 levels were detected using the Amplex Red Hydrogen Peroxide/Peroxidase 
Assay Kit (Molecular Probes). Single cell hepatocyte suspensions were obtained from fresh liver 
samples and red blood cells were removed using a percol gradient. Reactions containing 50μM 
Amplex Red reagent, 0.1 U/mL horse radish peroxidase and 1x10
5 
hepatocytes in 50mM sodium 
phosphate buffer, pH 7.4, were incubated for 30 minutes at 37
o
C. Fluorescence was measured 
with a microplate reader using excitation at 530nm and fluorescence detection at 590nm. 
Absolute H2O2 levels were determined in relationship to a standard curve.  
Hepatic superoxide was visualized using dihydrorhodamine 123 (DHR) (Molecular 
Probes/Invitrogen) fluorescent imaging. Hepatocytes were harvested similarly to the H2O2 assay. 
Hepatocytes were washed in 1XPBS, resuspended in media and incubated with 100μL of 
25μg/mL solution of DHR in the dark at 37oC for 20 minutes. Hepatocytes were counted and 
cytospins were performed with 1X10
6
 cells. Images were obtained via confocal microscopy 
using excitation 596nm, detection at 600-650nm and magnification 63X [61]. Nuclei were 
stained with 4',6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich).   Mean red fluorescent 
values were determined by averaging the fluorescence within a set number of pixels placed over 
5 areas within a 63X field, 3 fields per sample.  Results were expressed on a scale of 0-250. 
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DNA damage in hepatocytes was detected using an anti-8-hydroxyguanosine (8-OHG) 
antibody (ab10802, Abcam) and the presence of phosphorylated ATM in hepatocytes was 
detected using an anti-phospho-Serine1981-ATM (p-ATM) antibody (#200-301-400, Rockland) 
on frozen liver sections. Liver samples were embedded in Tissue-Tek O.C.T., flash frozen in 
liquid N2 and sectioned at 8-10 μM. Sections were fixed in a mixture of 3 parts acetone, one part 
pure ethanol and washed in 1XPBS.  Sections were blocked with casein/10% donkey serum for 
20 minutes at room temperature, washed in 1XPBS and then incubated with goat anti-8-OHG 
antibody (1:100 dilution) for 1 hour at 37
o
C or mouse anti-p-ATM antibody (1:200 dilution) 
overnight at 4
o
C in a humidifying chamber. Sections were washed in 1XPBS and treated with 
secondary antibodies labeled with Texas Red (1:500 dilution; Jackson ImmunoResearch). Nuclei 
were labeled with 4',6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich). For 8-OHG 
quantification, the percentage of positive 8-OHG cells was calculated over three 80X fields from 
three different mice per group. 
 
Western Blotting 
Cells were harvested and solubilized in RIPA buffer as described previously [62] 
followed by sonication. Total protein was quantified by Bradford assay, resolved on 6% to 14% 
SDS-PAGE gels, and subjected to immunoblotting using antibodies against PUMA (Abcam, 
#ab9643) and anti-beta actin (Sigma, #A5441). Western-blot imaging and quantification was 
performed using a Versa Doc Imaging System (Bio-Rad Laboratories). 
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Statistical Analyses 
Parametric data were analyzed utilizing one-way analysis of variance followed by 
Tukey’s post-test or by t test. Nonparametric data were analyzed by the Mann-Whitney-U test 
followed by Dunn’s post test. P values of ≤0.05 were considered statistically significant. Data 
are presented as mean ± standard error of the mean unless otherwise specified. All analyses were 
made with GraphPad Prism version 5.0 for Windows (GraphPad Software). 
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CHAPTER THREE: 
RESULTS 
Hepatic oxidative stress is promoted by high fat diet feeding. Feeding mice a high fat diet 
with cholesterol and cholic acid leads to increased expression of oxidative stress-related genes 
[63]. We directly measured oxidative stress associated with excessive fat consumption by 
harvesting hepatocytes from mice fed either a standard diet (SD) or a high fat diet (HFD) for 8 
weeks and performing Amplex Red staining to detect H2O2 and dihydrorhodamine (DHR) 
staining to detect superoxide species. Hepatocytes from
 
mice fed the HFD (n=4) showed 
significantly elevated levels of H2O2 compared to SD fed mice (n=3) (Figure 4A; *p<0.05). 
Superoxide levels, as measured by DHR staining, also were significantly increased in 
hepatocytes from HFD-fed mice as compared to those from SD-fed animals (Figure 4B and 4C; 
*p=0.01). Quantitative PCR analysis of the NADPH oxidase p22phox gene, which plays a 
central role in superoxide production [63], additionally was performed. Consistent with the H2O2 
and superoxide quantification, there were significant increases in p22phox expression in livers 
from HFD fed mice compared to those from mice fed SD (Figure 4D; *p=0.002). These data 
indicate that HFD feeding causes increased oxidative stress in hepatocytes.  
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Figure 4: High fat diet feeding induces hepatic oxidative stress. Atm
+ 
and Atm
-/- 
mice were 
fed SD or HFD for 8 weeks. Hepatocytes were then harvested and analyzed for (A) hydrogen 
peroxide production (Amplex-Red assay) or (B, C) the presence of superoxide 
(dihydrorhodamine assay). (A) Comparison of hydrogen peroxide levels showed that hepatocytes 
from mice fed the HFD (n=4) produced significantly more hydrogen peroxide compared to mice 
fed the SD (n=3) (*p<0.05, Student’s t-test). Scatter dot plot results are expressed as mean 
±SEM. (B) Comparison of the mean red fluorescence of DHR stained livers from SD and HFD 
fed groups (n=3 for both groups) showed that mice fed the HFD displayed significantly more red 
fluorescence than the SD fed mice (*p=0.01, Student’s t-test). Results are expressed as mean± 
SEM on a scale of 0-250. (C) Dihydrorhodamine (DHR) fluorescent staining of hepatocytes 
harvested from mice fed the SD (top panels) and HFD (lower panels). Scale bars represent 5μm. 
(D) Quantitative PCR analysis of the NADH/NADPH oxidase p22 phox gene from mice fed SD 
or HFD demonstrated significant increases in the HFD group compared to the SD group 
(*p=0.002, Student’s t-test). Gene expression was normalized to Gapdh expression and was 
compared by the ΔΔCT method. 
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High fat diet feeding induces hepatomegaly, steatohepatitis and ATM activation, and 
promotes hepatic fibrosis in an Atm-dependent manner. ATM activation plays an important 
role in the cellular response to ROS, and A-T patients display increased sensitivity to oxidative 
stress [13,42,64].  We therefore assessed ATM pathway activation in mice following HFD 
feeding via immunofluorescent staining of liver sections using an antibody that detects 
phosphorylated, active ATM (pS1987 of mouse ATM, corresponding to pS1981 of human ATM) 
[49].  Hepatocytes from Atm
+
 (Atm
+/+ 
and Atm
+/-
) HFD fed mice displayed both nuclear and 
cytoplasmic foci containing p-ATM, while hepatocytes from Atm
+ 
SD fed mice did not, 
confirming hepatic ATM activation in the Atm
+
 HFD fed group (Figure 5A). The majority of the 
foci appeared to be localized to the periphery of the nucleus. The detection of HFD-induced 
ATM phosphorylation was specific, as no staining was observed in Atm
-/- 
hepatocytes from mice 
fed either diet. We next tested the ability of Atm-deficient mice to respond to HFD feeding. 
Livers were examined grossly and microscopically after 8 weeks of feeding SD or HFD to 
determine if HFD feeding induced hepatic changes consistent with NAFLD. For all measures 
described below, we observed no significant differences between Atm
+/+ 
and Atm
+/-
 mice and 
therefore in most cases present combined data for these genotypes under the label Atm
+
. 
Irrespective of Atm status, there was 100% prevalence of fatty liver development in mice fed the 
HFD (n=22), whereas all mice fed the SD (n=23) had grossly normal livers (Figure 5B). Mice 
fed the HFD also had marked increases in liver weight (Figure 5C; *p< 0.0001), but not in total 
body weight (Figure 5D) compared to mice fed the SD, indicating that the HFD induced hepatic 
fat accumulation independent of obesity. Consistent with previous reports [58,65,66] Atm
-/-
 mice 
had slightly lower body weights compared to Atm
+
 mice regardless of diet (Figure 5D). Upon 
both H&E and Oil-red-O staining, hepatocytes from HFD fed Atm
+/+
 and Atm
-/-
 mice displayed 
23 
marked cellular hypertrophy and both microvesicular and macrovesicular steatosis (Figure 6A). 
In contrast, there was no abnormal hepatic fat accumulation in mice fed the SD. Further, mice 
fed the HFD had significantly higher fatty liver scores compared to SD fed controls irrespective 
of Atm genotype (Figure 6B,*p< 0.0001). These data demonstrate that 8 weeks of HFD feeding 
produced marked hepatic steatosis consistent with NAFLD in both Atm-expressing and Atm-
deficient mice. 
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Figure 5: High fat diet feeding induces grossly evident fatty liver without fat accumulation 
in other tissues: Atm
+ 
and Atm
-/- 
mice were fed SD or HFD for 8 weeks. Liver weight, body 
weight, and liver appearance were evaluated post euthanasia. Hepatocytes were then harvested 
and analyzed by immunofluorescence. (A) Frozen sections of livers from Atm
+/+
 mice fed SD or 
HFD
 
and Atm
-/- 
mice fed the HFD were labeled with anti-phospho-ATM (p-ATM) antibody and 
examined by confocal microscopy. Blue fluorescence signals represent DAPI stained nuclei and 
positive p-ATM foci fluoresce red. Scale bars represent 2.5 μm. (B) Representative images of 
liver from SD and HFD groups at the time of euthanasia. Scale bars represent 0.5cm. (C) 
Comparison of liver weights and (D) total body weights of mice of the indicated genotypes after 
8 weeks of HFD or SD feeding showed that mice fed the HFD had marked increases in liver 
weight compared to mice fed the SD (*p< 0.0001, Student’s t-test). Results are expressed as 
mean ± SEM.  
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Figure 6: High fat diet feeding induces hepatic steatosis and hepatitis regardless of Atm 
status, but leads to more fibrosis in Atm
+
 livers. H&E (A, first row, scale bars represent 
20μm), Sirius red (A, second row, scale bars represent 20μm) and Oil-Red-O (A, third row, scale 
bars represent 10μm) sections from mice fed SD (n=20) or HFD (n=25) for 8 weeks were scored 
blindly on a scale of 0-4 for fat accumulation (B), inflammation (C) and fibrosis (D). Results are 
expressed as mean ± SEM. Statistical values were obtained using Mann-Whitney-U test followed 
by Dunn’s post test. Comparison of scores between HFD and SD fed mice showed that 
regardless of Atm status, mice fed HFD had significantly higher fatty liver (B;*p< 0.0001), 
inflammation (C; *p< 0.05 ) and fibrosis (D; **p< 0.05) scores when compared to mice fed SD. 
Additionally, Atm
+ 
mice fed the HFD developed significantly higher fibrosis scores (D, ***p< 0.05 ) 
compared to Atm
-/-
 mice. Differences in fibrosis were highlighted by fewer Sirius red positive foci in Atm
-
/-
 mice (A, second row, arrows). H&E staining of livers from SD fed Atm
+
 and Atm
-/-
 mice revealed 
histologically normal liver, while mice of both genotypes, when fed the HFD, displayed cellular 
hypertrophy and accumulation of microvesicular (arrow head) and macrovesicular (thin arrows) steatosis, 
and portal inflammation (thick arrows). Mice fed the SD did not develop inflammation. Oil Red-O 
staining confirmed the presence of marked lipid accumulation in HFD fed livers. 
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Additional hepatic phenotypes resulting from 8 weeks of HFD feeding were evaluated based on 
H&E staining and pico-sirius red staining for collagen. Livers from both Atm
+ 
and Atm
-/- 
mice 
fed the HFD demonstrated moderate, predominantly peri-portal, mixed inflammatory cell 
infiltrates (Figure 6A). In contrast, there were no hepatic inflammatory lesions in mice fed the 
SD. Further, all mice fed the HFD, regardless of genotype, had significantly higher inflammation 
(Figure 6C, *p< 0.05) and fibrosis (Figure 6D, **p< 0.05) scores when compared to mice fed the 
SD. Notably, Atm
+ 
HFD fed mice developed significantly more fibrosis than Atm
-/-
 mice (Figure 
6D, ***p< 0.05). Differences in fibrosis development were highlighted by fewer and smaller 
pico-sirius red-positive foci in the livers of Atm
-/-
 mice as compared to those of Atm
+
 mice 
(Figure 6A). These data demonstrate that 8 weeks of HFD feeding produces marked 
steatohepatitis regardless of Atm status and that subsequent fibrosis is dependent, at least in part, 
on ATM.  
 
High fat diet feeding induces oxidative nucleic acid damage but limited histone H2AX 
phosphorylation. To understand the basis for the effects of Atm deficiency on HFD- induced 
liver pathology we evaluated whether Atm loss affects ROS levels in HFD fed mice.  To a similar 
extent as was observed in Atm
+
 mice (Figure 4), HFD feeding of Atm
-/-
 mice caused increased 
H2O2 and superoxide accumulation relative to SD fed mice (Figure 7A, *p=0.004; 7B, *p=0.01 ). 
Levels of 8-hydroxyguanosine (8-OHG), an oxidized nucleotide and marker of oxidative nucleic 
acid damage were then quantified to determine if the elevated oxidative stress in fatty livers 
resulted in hepatocyte DNA damage. There was minimal staining for 8-OHG in the SD group 
while there were multiple 8-OHG positive aggregates within the nuclei and cytoplasm of 
hepatocytes from HFD fed mice (Figure 7C). In some nuclei, 8-OHG appeared to be localized to 
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the periphery of the nucleus. Quantification of 8-OHG positive cells showed that there were 
significantly more positive cells in the Atm
+
 and Atm
-/-
 groups fed the HFD than in mice fed the 
SD (Figure 7D; *p= 0.001). There was no significant difference between Atm
+
 and Atm
-/-
 HFD 
fed groups. These findings indicate that the HFD causes oxidative nucleic acid damage in both 
Atm-expressing and Atm-deficient mice. 
 
To determine the nature and extent of the DNA damage response induced by HFD feeding, we 
performed immunohistochemistry on liver sections from HFD and SD fed groups and quantified 
the levels of γ-H2AX, the phosphorylated form of histone H2AX which occurs in response to 
DNA DSBs [67]. In contrast to our earlier observations of HFD feeding-induced ATM 
phosphorylation (Figure 5A), there was minimal positive staining for H2AX phosphorylation in 
hepatic nuclei from mice of all experimental groups (Figure 7E; *p<0.0001; 7F; 7H; 7I). 
Importantly, significant increases in γ-H2AX staining were detected in liver sections from 
control mice treated with ionizing radiation (Figure 7E and 7G). Overall, these data demonstrate 
that there is DNA damage in HFD fed hepatocytes without substantial phosphorylation of 
H2AX. 
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Figure 7: High fat diet feeding increases hepatic nucleic acid damage but does not induce 
detectable phosphorylation of histone H2AX. (A-B) Hepatocytes were harvested from mice of 
the indicated genotypes and analyzed for hydrogen peroxide production (amplex-red assay) and 
the presence of superoxide (dihydrorhodamine assay). The data for Atm
+
 mice are identical to 
those shown in Figure 4. (A) Hepatocytes from mice fed the high fat diet (n=4/group) produced 
significantly more hydrogen peroxide compared to standard diet fed mice (n=3) (*p=0.004). 
Scatter dot plot results are expressed as mean ±SEM. (B) Comparison of the mean red 
fluorescence of DHR stained livers from standard diet, and Atm
+
 and Atm
-/- 
high fat diet fed 
groups (n=3/groups) showed that, regardless of genotype, mice fed the high fat diet displayed 
significantly more red fluorescence than the standard diet fed mice (*p=0.01). There was no 
difference in mean red fluorescence between high fat diet groups.  Mean fluorescent values were 
determined by averaging the fluorescence within a set number of pixels placed over 5 areas 
within a 63X field, 3 fields per sample.  Results are expressed as mean± SEM on a scale of 0-
250. (C) Frozen sections of livers from mice fed SD (right) or the HFD (left) were labeled with 
anti- 8-hydroxyguanosine (8-OHG) antibody and examined by confocal microscopy. Blue 
fluorescence signals represent DAPI stained nuclei and positive 8-OHG foci fluoresce red. Scale 
bars represent 2.5 μm. (D) Quantitation of the experiment described in (C) highlights that there 
were significantly more 8-OGH positive nuclei per 80X field in the Atm
+
 and Atm
-/-
 groups fed 
the HFD than in the Atm
+
 group fed the SD (*p= 0.001, Student’s t-test) (n=3 in each group). 
Results are expressed as mean± SEM. The percentage of 8-OHG positive nuclei out of total 
DAPI positive nuclei was calculated over three 80X fields. (E) Immunohistochemistry was 
performed to identify phosphorylated histone H2AX in liver sections from HFD and SD fed mice 
of the indicated genotypes (n=3/group) and revealed that there was minimal staining in these 
groups while there was significantly more staining detected in Atm
+
 livers treated with 10 Gy IR 
regardless of genotype (*p<0.0001, Student’s t-test). Data on graph represent mean ± SEM. (F-I) 
Representative images of liver sections stained with anti-γH2AX antibody (brown nuclei, arrow) 
from (F) Atm
+/+ 
standard diet, (G) Atm
+/+ 
irradiated and (H) Atm
+/+
 high fat diet and (I) Atm
-/-
 
high fat diet fed groups. Sections were counterstained with hematoxylin. Quantification is shown 
in Figure 7E. Scale bars represent 15μm. 
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High fat diet feeding increases Atm-dependent steatoapoptosis. One of the outcomes of ATM 
pathway activation is apoptosis [68], and steatoapoptosis is important in fatty liver progression 
[19,21,22]. The induction of apoptosis by HFD feeding was evaluated by terminal uridine 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining of liver sections (n=5-
10/group; Figure 8 C-F). TUNEL staining detects DNA fragmentation, a characteristic feature of 
apoptotic cells. HFD groups contained significantly more TUNEL-positive hepatocytes 
compared to SD groups, which exhibited minimal positive staining (Figure 8A; *p≤0.0001). 
Notably, among the HFD fed mice,  Atm
+
 hepatocytes underwent significantly more apoptosis 
than those from Atm
-/- 
mice (Figure 8A; **p<0.001). To dissect the molecular basis for this 
ATM-dependent apoptotic response to HFD feeding, we used quantitative PCR to measure the 
expression of the DNA damage-responsive, pro-apoptotic gene Puma [69]. HFD fed Atm
+ 
mice 
(n=12) had increased Puma expression when compared to all other groups, including HFD fed 
Atm-deficient mice (n=10-12/group), indicating that PUMA is induced after HFD feeding 
through a mechanism that requires ATM (Figure 8B; *p<0.01). HFD feeding similarly resulted 
in increased PUMA protein levels as measured by immunoblotting of livers from Atm
+
 HFD fed 
mice, and this induction of PUMA was greatly reduced in samples from Atm-deficient mice 
(Figure 8G). There were also appreciable increases in Fas receptor expression, a component of 
the extrinsic pathway of apoptosis, between SD and HFD groups, but the levels were nearly 
identical between Atm
+
 and Atm
-/-
 HFD groups (Figure 8H). Together, these data indicate that 
HFD feeding induces ATM-dependent upregulation of PUMA and hepatocyte apoptosis.  
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Figure 8: High fat diet feeding induces Atm-dependent steatoapoptosis: (A) TUNEL staining 
to identify apoptotic cells in liver sections from mice of the indicated group (n=5-10/group) was 
quantified and revealed that HFD groups, regardless of genotype, contained significantly more 
TUNEL-positive hepatocyte nuclei compared to the SD (*p<0.0001, Student’s t-test).   
Comparison of TUNEL quantification from HFD fed mice showed that hepatocytes from Atm
+
 
mice underwent significantly more apoptosis than those from Atm
-/-
mice (**p<0.001 ). Data 
represent mean ± SEM. (B) Quantitative PCR analysis of the pro-apoptotic gene Puma from 
Atm
+
 and Atm
-/-
 mice fed either SD or HFD for 8 weeks demonstrated that the Atm
+
 HFD mice 
(n=12) had increased Puma expression when compared to all other groups (n=10-12/group) 
(*p<0.01, Student’s t-test ). (C-F) Representative images of TUNEL stained (brown nuclei, 
arrow) liver sections from Atm
+/+
 and Atm
-/-
 mice from standard and high fat diet fed groups 
demonstrated that there were minimal TUNEL positive hepatic nuclei when the mice were fed 
the standard diet, while there were TUNEL positive apoptotic  nuclei when the mice were fed the 
high fat diet.  Sections were counterstained with hematoxylin. Quantification is shown in Figure 
5A. Scale bars represent 7μm. (G) Total protein lysates were prepared from frozen liver section 
after feeding SD or HFD and immunoblotted for PUMA. Liver lysates from untreated (-IR) or 
ionizing radiation treated (+IR, 2 hours post-5Gy) mice were used as negative and positive 
controls respectively. β-ACTIN was used as a loading control. (H) Quantitative PCR analysis of 
the Fas Receptor (CD95) gene expression in livers from standard diet (n=5), Atm
+
 high fat diet 
(n=6) and Atm
-/-
 high fat diet (n=5) groups demonstrated that regardless of genotype, there was 
minimal increase in Fas Receptor expression in high fat diet fed hepatocytes when compared to 
mice fed the standard diet (via t-test). 
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CHAPTER FOUR: 
CONCLUSIONS 
NAFLD represents an array of hepatic lesions ranging from benign steatosis to hepatic 
inflammation and cirrhosis. Because of the increasing prevalence of this disease, a more 
thorough understanding of the factors involved in NAFLD progression is warranted. This study 
investigated the roles of ATM, a protein kinase involved in maintaining genomic stability, in a 
diet-induced model of NAFLD/NASH. Other models of NASH use genetic defects, chemical 
agents, or nutrient depletion to induce steatohepatitis and hepatic fibrosis. Nutritional models, 
such as sucrose- and fructose-rich diets, cause only minimal hepatic steatosis and inflammation 
[63]. Conversely, the diet used in this study closely recreated the NAFLD phenotype of 
steatohepatitis and fibrosis by coupling high fat with cholesterol and cholic acid.  Fat 
accumulation elsewhere in the body was not observed, presumably due to the fat source and the 
relatively short time period mice were fed the HFD. 
 
Eight weeks of HFD feeding caused hepatic phenotypes in mice consistent with NAFLD, 
including hepatic steatosis and oxidative stress indicated by elevated levels of ROS and 
increased expression of p22phox, a gene encoding a subunit of NADPH oxidase. Hepatic lipid 
accumulation is considered an initiating factor in NAFLD pathogenesis and renders hepatocytes 
susceptible to oxidative stress. High levels of oxidative stress correlate with increasing severity 
of liver disease in humans [5]. In this study, we showed that HFD-induced steatohepatitis and 
hepatic oxidative stress were present in both Atm
+ 
and Atm
-/-
 mice, which recapitulates essential 
38 
components of NAFLD/NASH and creates a hepatic environment ideal to study the effects of 
Atm loss on NAFLD progression.  
 
Chronic liver injury results in fibrosis [36,70].  After 8 weeks of HFD feeding, Atm
+
 mice 
exhibited more hepatic fibrosis than Atm
-/-
 mice.  Interestingly, the same trend was observed for 
hepatic apoptosis, with Atm
+
 mice exhibiting more hepatocyte apoptosis than Atm
-/-
 mice after 
chronic HFD feeding. This is consistent with data indicating that apoptosis contributes to fibrosis 
in NAFLD/NASH progression as well as in vitro studies which suggest a direct link between 
hepatocyte apoptosis and fibrosis [20,21,22,71]. Although the precise mechanistic details have 
not been fully resolved, available data indicate that apoptosis and cell clearance stimulate 
quiescent hepatic stellate cells, triggering their transformation to a myofibroblast phenotype and 
subsequent extracellular matrix deposition [12,72].  
  
Differences in fibrosis and steatoapoptosis between HFD fed Atm
+
 and Atm
-/-
 mice 
correlated with expression levels of the pro-apoptotic gene Puma at both the mRNA and protein 
levels. Excessive ROS production, as seen in this model, may induce apoptosis via various 
pathways, including the intrinsic pathway of apoptosis which involves PUMA signaling [12,73]. 
Recent studies identify PUMA as an important factor in hepatocyte steatoapoptosis, and PUMA 
inhibition or deficiency leads to decreased hepatic apoptosis [25,27,32,73]. Moreover, hepatic 
Puma expression is increased in NASH patients as compared to expression levels in NAFLD or 
healthy patients, implicating PUMA in fatty liver disease progression, likely through functions 
related to steatoapoptosis and fibrosis formation [19,25]. Puma activation relies primarily on the 
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DNA damage inducible transcription factor p53 [73]. ATM is an upstream activator of p53, 
linking ATM to PUMA-mediated apoptosis in a manner consistent with the ATM-dependent 
upregulation of Puma expression in this model. We also evaluated components of the extrinsic 
pathway of apoptosis, including Fas and Fas receptor, via quantitative PCR. There were 
appreciable increases in Fas receptor expression between SD and HFD groups, but the levels 
were nearly identical between Atm
+
 and Atm
-/-
 HFD groups (Figure 8H). Further, there was no 
detectable expression of Fas ligand in any treatment group (data not shown). Although we 
cannot entirely rule out involvement of the extrinsic pathway of apoptosis in high fat mediated 
apoptotic cell death, it does not appear to account for differences observed in hepatocyte death 
between HFD fed Atm
+
 and Atm
-/-
 mice.  
 
One of the most common causes of hepatic genomic instability is ROS-induced DNA 
damage [38,74]. In this study chronic HFD feeding caused oxidative nucleic acid damage 
regardless of Atm status as evidenced by the similar percent of 8-OHG-positive cells in HFD fed 
Atm
+
 and Atm
-/-
 mice. Interestingly, phosphorylation of histone H2AX, a marker of DNA DSBs, 
was not detectably induced in the HFD groups. γ-H2AX positive hepatocytes were present in IR 
treated control samples, demonstrating that the immunohistochemical assay for γ-H2AX was 
functional. Thus, hepatocytes are capable of phosphorylating H2AX but do not do so to a 
detectable level in response to HFD feeding.  Studies show that ROS-induced ATM activation 
can occur in the absence of DNA DSBs, and this is associated with phosphorylation of only a 
subset of ATM targets that does not include H2AX [41,42]. Taken together, these data suggest 
that ATM-mediated fatty liver phenotypes may be the result of an oxidative stress response 
rather than the classical γ-H2AX associated signaling pathway. The observation of phospho-
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ATM in the cytoplasm of fat-laden hepatocytes provides further support for a ROS mediated 
mechanism of ATM activation [41]. Within the nucleus, both 8-OHG and p-ATM seemed to be 
more abundant at the nuclear periphery. One hypothesis to explain the observed localization of 
8-OHG is that the low permeability of reactive oxygen species limits their mobility through the 
nuclear membrane, thus creating the most extensive oxidative damage at the nuclear periphery 
[75]. The observed staining patterns also may relate to previous in vitro studies demonstrating 
that oxidative damage preferentially occurs in heterochromatin, which is predominantly located 
in the nuclear periphery, and that ATM is critical in repairing this damage [76].  
 
NASH carries a risk of HCC formation. It is well established that apoptosis promotes 
hepatic fibrosis, and both are key risk factors for HCC development, with hepatic fibrosis and 
cirrhosis being present in 80-90% of patients with HCC [36,37,77]. In this study, steatoapoptosis 
and fibrosis were observed at highest levels in Atm-expressing HFD fed mice, indicating that the 
ATM pathway promotes both during hepatic lipid accumulation. Although apoptosis is generally 
regarded as a tumor suppressing mechanism that clears damaged cells at risk of undergoing 
malignant transformation, there also are several examples of tumor promoting effects of 
apoptosis, including in HCC [24].  Here, the ultimate effect of reduced fibrosis and apoptosis on 
tumor development could not be determined because Atm
-/-
 mice develop thymic lymphoma at 3-
4 months of age [58,65,66] preventing long-term evaluation of liver carcinogenesis. However, 
based upon the recognized influences of apoptosis and fibrosis during HCC development, it is 
reasonable to hypothesize that the observed Atm-dependent increases in these processes could 
promote hepatic carcinogenesis. Therefore, pharmacological inhibition of ATM may be 
beneficial to limit fibrosis formation and NAFLD progression. 
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Figure 9 
 
 
 
 
 
 
Figure 9: Hepatic fat accumulation triggers oxidative stress and activation of an ATM-
mediated DNA damage response, resulting in steatoapoptosis and hepatic fibrosis: ATM is 
activated during high fat diet feeding, resulting in upregulation of pro-apoptotic PUMA, leading 
to increased hepatic apoptosis and compensatory fibrosis formation. Atm-dependent increases in 
these processes could promote hepatic carcinogenesis. 
 
Summary and Future Directions 
In summary, these findings suggest that hepatic fat accumulation triggers oxidative stress 
and activation of an ATM-mediated DNA damage response, resulting in steatoapoptosis and 
hepatic fibrosis (Figure 9). Human trials have been inconclusive regarding effective therapy for 
NAFLD, including antioxidants, insulin sensitizers, weight loss, or a combination of these 
modalities [78,79]. However, our data suggest that modulation of ROS levels and ATM 
activation may provide novel therapeutic targets to prevent the progression of NAFLD. The 
mouse model described here provides a system for further experimental evaluation of how 
candidate therapeutics like the antioxidants NAC and Tempol, which suppress the ROS to which 
ATM responds [80,81,82], impact fatty liver disease. 
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In addition to developing longer lived animal models to study fatty liver disease 
progression, assessing the mechanisms driving fibrosis formation is an important aspect that 
warrants further evaluation. Since activated hepatic stellate cells are responsible for collagen 
production and deposition, elucidating the reasons for stellate cell activation and the fate of the 
cells following activation may provide insight into the central steps involved in disease 
progression and provide additional targets for therapy. 
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